UGI Does Not Confer Resistance to Biologic Therapy: UEGW 2026.
Upper gastrointestinal involvement in Crohn’s disease was not associated with reduced biologic treatment persistence, but it was linked to an increased risk of intestinal resection, particularly in patients with combined L4a and L4b involvement.
